Method and composition for treating psoriasis, seborrheic dermatitis and eczema
US5681593A · kind A · utility
2Cited by
2References
20Claims
0Family size
Inventors
Key dates
| Filing date | Jul 18, 1995 |
| Grant date | Oct 28, 1997 |
| Priority date | — |
| Expiry date | Jul 18, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Psoriasis, seborrheic dermatitis and eczema are treated by oral administration of inorganic nickel compound(s), with or without inorganic bromide(s). In an especially preferred embodiment, the nickel compound used to treat these diseases is NiBr.sub.2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.